Rabies Post-Exposure Prophylaxis in Pregnancy
Pregnant patients should absolutely receive rabies post-exposure prophylaxis (PEP) without delay—pregnancy is not a contraindication, and the near-100% fatality rate of rabies far outweighs any theoretical vaccine risks.
Safety Profile in Pregnancy
Modern cell-culture rabies vaccines (HDCV and PCECV) are safe during pregnancy, with extensive evidence supporting their use:
- A prospective study of 202 pregnant Thai women receiving rabies PEP showed adverse reaction rates similar to non-pregnant patients, with no increased pregnancy complications 1
- A Chinese follow-up study of 72 pregnant women found no moderate or severe adverse effects, with all 67 delivered infants showing normal development 2
- Multiple smaller studies consistently demonstrate safety for both mother and fetus 3, 4
- Available data indicate that administering rabies vaccines during pregnancy is safe and effective 5
Recommended Vaccination Schedule
For Previously Unvaccinated Pregnant Patients
The standard 4-dose regimen should be administered 6:
- Vaccine (HDCV or PCECV): 1.0 mL IM in the deltoid on days 0,3,7, and 14
- Human Rabies Immune Globulin (HRIG): 20 IU/kg body weight on day 0
- Infiltrate the full dose around and into wounds if anatomically feasible
- Inject any remaining volume IM at a site distant from vaccine administration
- Can be given up to day 7 if not administered initially
- Never administer in the same syringe or site as the first vaccine dose
For Previously Vaccinated Pregnant Patients
Simplified 2-dose regimen 6:
- Vaccine: 1.0 mL IM in deltoid on days 0 and 3
- No HRIG needed
Critical Implementation Points
Wound Management
Begin immediately with thorough wound cleansing using soap and water. If available, use a virucidal agent (povidone-iodine solution) to irrigate wounds 6.
Injection Site
- Adults: Deltoid area only (never gluteal—results in lower antibody titers) 7, 6
- The same dose and volume used for non-pregnant adults applies to pregnant patients
Timing
- Initiate PEP as soon as possible after exposure
- Day 0 is the day the first vaccine dose is administered
- Treatment should never be withheld or delayed due to pregnancy 1
Common Pitfalls to Avoid
Delaying treatment due to pregnancy concerns: This is the most dangerous error. Rabies is nearly 100% fatal once symptomatic, while vaccines are proven safe in pregnancy.
Using gluteal injection site: This results in diminished immunologic response 6
Administering HRIG and vaccine in the same syringe or site: HRIG can partially suppress active antibody production if not properly administered 7
Exceeding recommended HRIG dose: More is not better—excess HRIG can suppress the vaccine response 7, 6
Recommending pregnancy termination: Education is needed to prevent unnecessary abortions due to unfounded concerns about rabies vaccination risk 2
Schedule Deviations
If doses are delayed by a few days, simply resume the schedule maintaining the same intervals between doses. For example, if the day 7 dose is given on day 10, administer remaining doses on days 17 and 31 7. Do not restart the entire series for minor delays.
Rationale
The evidence base is clear and consistent: the mortality risk from untreated rabies exposure (nearly 100% fatal) vastly exceeds any theoretical risk from vaccination during pregnancy. The ACIP guidelines apply to "all age groups" without pregnancy exclusions 6, and multiple prospective studies demonstrate excellent safety profiles in pregnant women 1, 2, 3. Mother-to-child rabies transmission is possible but rare 4, making maternal PEP the priority intervention.